> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Recros Medica De Novo Submission for Nuvellus
- URL: https://www.fdaweb.com/recros-medica-de-novo-submission-for-nuvellus/
- Published: 2019-05-07T12:00:00.000Z
- Updated: 2026-09-15T01:24:55.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5144050

Recros Medica has filed a *de novo* regulatory submission for the Nuvellus Focal Contouring System. The device uses the company’s “Rotational Fractional Resection” technology to provide medical aesthetic physicians a single treatment option to improve submental (neck and jowl) contouring. “Nuvellus is a novel alternative to current skin contouring approaches such as traditional surgery and energy-based devices,” the company says. It comprises an integrated console, reusable surgical handpiece and differentiated consumable attachments for specific contouring applications.